TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown these tests fail to improve patient prognosis. Intravascular imaging, such as intravascular ultrasound (IVUS), has shown that plaque burden, low-attenuation plaques, and minimal luminal area are important prognostic markers of coronary artery disease.

Coronary computed tomography angiography (CTA) accurately assesses atherosclerotic plaque characteristics, and several studies have highlighted its significant prognostic value. Notably, quantitative CTA with artificial intelligence (AI) enables comprehensive, automated quantitative analysis of the arterial tree.

The aim of this study was to identify the quantitative characteristics of atherosclerosis assessed by CTA and their association with major adverse cardiovascular events (MACE). Additionally, the prognostic value of these characteristics was compared against traditional clinical risk scores. 

Primary endpoint included all-cause mortality, acute myocardial infarction (AMI), stroke, heart failure (HF), late revascularization (>90 days), and hospitalization for unstable angina. Secondary endpoint was all-cause mortality and AMI.

Read also: TCT 2024 | Distal Radial vs Transradial Approach in STEMI Patients.

A total of 3,551 patients were analyzed and follow-up for mean 4.8 years. Mean patient age was 58, they were mostly male. Most were at intermediate risk according to the Diamond-Forrester score. During follow-up, 5% of patients experienced adverse events, including death (n=34), AMI (n=24), stroke (n=12), hospitalization for HF (n=23), hospitalization for unstable angina (n=17), and late revascularization (n=84). The main predictors of MACE were stenosis luminal diameter and non-calcified plaque volume.

This is the first multicenter registry using artificial intelligence to quantify coronary artery disease. The use of AI-QCT can guide both anti-atherosclerotic therapies and interventional cardiology procedures, aimed at reducing adverse events during follow-up.

Original Title: CONFIRM-2: AI-guided Quantitative Coronary CT Angiography (AI-QCT) Technology in Patients With Suspected Coronary Artery Disease.

Reference: Alexander van Rosendael MD PhD et al TCT 2024.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | FLAVOUR II: Angiography-Derived FFR-Guided vs. IVUS-Guided PCI

Physiological assessment is effective when it comes to decision-making for percutaneous coronary intervention (PCI). However, despite the available evidence, its use remains limited. AngioFFR...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...